What is PT Siloam International Hospitals Tbk Debt-to-EBITDA?
PT Siloam International Hospitals TbkFRA:2LS 94 Debt-to-EBITDA is 0.78 as of Mar. 2026, which is 42% above its 10-year median of 0.55. GuruFocus rates FRA:2LS with a GF Score™ of 94/100 and a GF Value™ of €0.13 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 477 Healthcare Providers & Services companies, PT Siloam International Hospitals Tbk ranks better than 74.21% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
FRA:2LS'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.26 Med: 0.55 Max: 1.8
Current: 0.77
During the past 13 years, the highest Debt-to-EBITDA Ratio of PT Siloam International Hospitals Tbk was 1.80. The lowest was 0.26. And the median was 0.55.
FRA:2LS's Debt-to-EBITDA is ranked better than 74.21% of 477
companies
in the Healthcare Providers & Services industry
Industry Median: 2.22
vs FRA:2LS: 0.77
PT Siloam International Hospitals Tbk (FRA:2LS) Debt-to-EBITDA Explanation
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
PT Siloam International Hospitals Tbk Debt-to-EBITDA Related Terms
PT Siloam International Hospitals Tbk Debt-to-EBITDA Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Siloam International Hospitals Tbk Debt-to-EBITDA Chart
FRA:2LS vs HCA, THC, DVA: Debt-to-EBITDA Comparison
For the Medical Care Facilities subindustry, PT Siloam International Hospitals Tbk's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Siloam International Hospitals Tbk Debt-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PT Siloam International Hospitals Tbk's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where PT Siloam International Hospitals Tbk's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Mar. 2026) EBITDA data.
PT Siloam International Hospitals Tbk (FRA:2LS) has a Debt-to-EBITDA of 0.78 as of Mar. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on PT Siloam International Hospitals Tbk. This is 42% above median its historical median of 0.55. Over the past decade, PT Siloam International Hospitals Tbk's Debt-to-EBITDA has ranged from 0.26 to 1.80. According to the industry distribution chart, PT Siloam International Hospitals Tbk ranks #123 out of 477 companies in the Healthcare Providers & Services industry, placing it in the top 25.8%.
Is PT Siloam International Hospitals Tbk's Debt-to-EBITDA too high?
PT Siloam International Hospitals Tbk's current Debt-to-EBITDA of 0.78 is 42% above median its 10-year median of 0.55. Over the past 10 years, this metric has ranged from a low of 0.26 to a high of 1.80. The Healthcare Providers & Services industry median Debt-to-EBITDA is 2.22. PT Siloam International Hospitals Tbk's value of 0.78 is 64.9% below this industry median. Based on the distribution chart, PT Siloam International Hospitals Tbk ranks #123 out of 477 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, PT Siloam International Hospitals Tbk has a GF Score™ of 94/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Siloam International Hospitals Tbk's Debt-to-EBITDA compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, PT Siloam International Hospitals Tbk ranks #123 out of 477 companies for Debt-to-EBITDA. This puts PT Siloam International Hospitals Tbk in the upper half of its industry. The industry median Debt-to-EBITDA is 2.22. PT Siloam International Hospitals Tbk's value of 0.78 is 64.9% below this benchmark. Historically, PT Siloam International Hospitals Tbk's own Debt-to-EBITDA has ranged from 0.26 to 1.80 over the past decade. While the company's 10-year median is 0.55 vs. the industry median of 2.22, PT Siloam International Hospitals Tbk has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Healthcare Providers & Services company?
The median Debt-to-EBITDA among Healthcare Providers & Services companies is 2.22, based on 477 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Siloam International Hospitals Tbk's current Debt-to-EBITDA of 0.78 is 64.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on PT Siloam International Hospitals Tbk. For the Healthcare Providers & Services industry, the median Debt-to-EBITDA is 2.22 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Siloam International Hospitals Tbk's current Debt-to-EBITDA is 0.78, which is 42% above median its own 10-year median of 0.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Siloam International Hospitals Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Siloam International Hospitals Tbk (FRA:2LS) is currently considered Modestly Undervalued. The stock's GF Value™ is €0.13, compared to a current price of €0.10 — trading 25.4% below its estimated fair value. The current Debt-to-EBITDA is 0.78, which is 42% above median its 10-year median of 0.55 and 64.9% below the Healthcare Providers & Services industry median of 2.22. PT Siloam International Hospitals Tbk's overall GF Score™ is 94/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For PT Siloam International Hospitals Tbk (FRA:2LS), the current Debt-to-EBITDA is 0.78 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Siloam International Hospitals Tbk (FRA:2LS) Overvalued in 2026?
Based on GuruFocus' analysis, PT Siloam International Hospitals Tbk stock appears to be undervalued.
The current stock price of €0.10 is trading 25.4% below its estimated GF Value™ of €0.13.
GuruFocus considers PT Siloam International Hospitals Tbk to be Modestly Undervalued.
Key valuation signals for FRA:2LS:
Debt-to-EBITDA: 0.78 (42% above median its 10-year median of 0.55)
GF Value™: €0.13 vs. price of €0.10 (25.4% below fair value)
Industry Position: 64.9% below the Healthcare Providers & Services median (#123 of 477)
No single metric tells the full story. See the FRA:2LS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Siloam International Hospitals Tbk Business Description
PT Siloam International Hospitals Tbk operates a network of hospitals in Indonesia. Its hospitals are located in the Greater Jakarta area and across Java, Sumatra, Kalimantan, Sulawesi, Bali, Nusa Tenggara, Ambon, and other areas across Indonesia, along with several Siloam Clinics. The company offers an integrated, one-stop care ecosystem designed to provide comprehensive healthcare services, spanning examination, diagnosis, clinical management, rehabilitation, and health education. Additionally, it offers special clinical services in the following segments, including neurosciences, neurology, digestive, cardiac, orthopedic, etc., by running the Center of Excellence and specialty centers. The company generates the majority of its revenue by offering hospitalization and outpatient services.
94GF Score
Get the complete analysis for FRA:2LS
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:2LS has been successfully added to your 
